Yarbrough Capital »

Newamsterdam Pharma Co Nv shares owned by Yarbrough Capital

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Yarbrough Capital from 13F filings

Historical chart of Yarbrough Capital investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Yarbrough Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Yarbrough Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $398k 24k 16.60
2024-06-30 $460k 24k 19.21
2024-03-31 $567k 24k 23.65

More positions owned by Yarbrough Capital

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Vanguard World Inf Tech Etf (VGT)
Broadcom (AVGO)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Alphabet Cap Stk Cl C (GOOG)
Diamondback Energy (FANG)
Qualcomm (QCOM)

View all positions for Yarbrough Capital

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
RA Capital Management
Viking Global Investors
Medicxi Ventures Management
Cormorant Asset Management
BVF
Woodline Partners
Jennison Associates
Henderson Group
Pictet Asset Management Holding SA
Siren
Deerfield Management Company
Avidity Partners Management

View all funds holding Newamsterdam Pharma Co Nv